COMP <GO>
MTD vs JNJ // GROSS PROFIT MARGIN
Mettler-Toledo International Inc. (NYSE) VS. Johnson & Johnson (NYSE) • 15-METRIC TALLY: MTD 4
— JNJ 9
▲ GROSS PROFIT MARGIN LEADER: JNJ
LAST: $1,674.81 (-2.55%) • MKT CAP: $34.44B
gross-margins
59.40%
LAST: $273.20 (-0.73%) • MKT CAP: $662.49B
gross-margins
67.90%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (MTD VS. JNJ)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | MTD | JNJ | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin ACTIVE | 59.40% | 67.90% | -8.50 | JNJ | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 30.40% | 25.50% | +4.90 | MTD | /roic <GO> |
| EV/EBITDA & P/E Valuation | 31.7x | 18.5x | +13.20 | JNJ | /valuation <GO> |
| Free Cash Flow Yield | 2.46% | 2.97% | -0.51 | JNJ | /fcf-yield <GO> |
| Operating Margin | 26.30% | 34.70% | -8.40 | JNJ | /operating-margins <GO> |
| Net Profit Margin | 21.60% | 28.50% | -6.90 | JNJ | /net-margins <GO> |
| Revenue Growth (YoY) | 4.00% | 6.00% | -2.00 | JNJ | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 11.09 | 5.59 | +5.50 | MTD | /balance-sheet <GO> |
| Piotroski F-Score Quality | 8/9 | 8/9 | 0.00 | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | 6.50% | 7.20% | -0.70 | MTD | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 65.4 | 60.4 | +5.08 | MTD | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 0.87 | 1.08 | -0.21 | JNJ | /macro-sensitivity <GO> |
| Forward P/E Multiple | 36.8x | 23.0x | +13.80 | JNJ | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $34.44B | $662.49B | -$628.06B | JNJ | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | MTD REV | JNJ REV | MTD GROSS % | JNJ GROSS % | MTD FCF | JNJ FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $4.03B | $94.19B | 59.4% | 67.9% | $848.6M | $19.70B |
| FY 2024 | $3.87B | $88.82B | 60.1% | 69.1% | $864.4M | $19.84B |
| FY 2023 | $3.79B | $85.16B | 44.0% | 44.0% | $795.4M | $18.96B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
MTD // BETA 0.87
JNJ // BETA 1.08